|
|
Within each of us...
there is an extraordinary defense force on constant alert to fight and eliminate infection. It is the immune system. At Kineta, our team of globally renowned scientists is developing unique medicines that enhance immunity and empower the human body to overcome disease.
-
5/22/2013 - VC: Kineta, Oligomerix gain fresh venture backing for R&D programs, FierceBiotech
-
5/21/2013 - Kineta, Scouring the World for Cash, Finds Oil Money, Xconomy
-
5/21/2013 - Global Oil Traders Fuel Kineta's Drug Pipeline
-
4/30/2013 - Seattle Biotech Kineta has a Plan for Faster Investor Returns, Puget Sound Business Journal
-
3/19/2013 - From Toxins to Therapeutics, TheScientist
-
2/7/2013 - RLB Holdings backs drug developer Kineta, AltAssets
-
2/5/2013 - Former oil trader, Yankees part-owner invests in Kineta, GeekWire
-
1/25/2013 - Two Kineta Drug Programs Featured in National Geographic Magazine
-
8/21/2012 - Kineta uses unorthodox strategy to push autoimmune drug into clinic
-
8/21/2012 - Kineta Announces Regulatory Clearance to Initiate a Phase 1 Clinical Trial for ShK-186
- More News Items...
|
©Sam Van Fleet Photographer
|
